Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bolus-infusion vs Sliding Scale Insulin for Intra-operative Glycemic Control
NCT05136157Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Nov 2021
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of human insulin in diabetes mellitus (DM) (2 arms), sponsored by Ain Shams University. Primary endpoint: Capillary Blood Glucose at 7 months. Started Nov 2021; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT05136157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05136157.